Abstract:Background: Non-alcoholic fatty liver disease (NAFLD), characterized as excessive lipid accumulation within hepatocytes, is growing in prevalence. The exploitation of effective drugs for NAFLD has been proven challenging. Herein, we aimed to establish a dietary model of hepatic steatosis using transparent zebrafish larvae in which high-throughput chemical screens could be conducted.Methods: Zebrafish larvae fed with high fat (HF) diet and high fat plus high cholesterol (HFC) diet were compared to the control. We analyzed intrahepatic lipid accumulation, biological indexes and various pathways including lipid metabolism, ER stress and inflammation. In addition, the effects of ezetimibe and simvastatin on HFC diet-induced steatosis were evaluated.Results: Zebrafish larvae fed with HF and HFC diets developed steatosis for 7 and 10 days. The incidence and degree of steatosis were more severe in HFC diet-fed larvae compared with the control and HF diet-fed larvae, suggesting that adding cholesterol to the HF diet promotes the hepatic lipid accumulation. These data were confirmed by the pathological observation. Biological indexes, free cholesterol (FC), total cholesterol (TC) and triacylglycerol (TG) were elevated in the liver of HFC diet-fed larvae compared with the control and HF diet-fed larvae. Additionally, the expression levels of endoplasmic reticulum (ER) stress and lipolytic molecules (atf6, hspa5, hsp90b1, pparab, cpt1a and acox3) were significantly up-regulated in the liver of HF and HFC diets-fed larvae compared to the control, whereas the expression of lipogenic molecules (acaca, fasn, srebf2, hmgcs1 and hmgcra) were decreased in the liver of HF and HFC diets-fed larvae compared to the control. To validate the reliability of the HFC model and utility value for screening potential anti-steaotsis drugs, HFC-fed larvae were treated with two accepted lipid-lowing drugs (ezetimibe and simvastatin). The results showed that these drugs significantly ameliorated HFC-induced steatosis.Conclusion: Our results demonstrate that the zebrafish larvae steatosis model established and validated in this study could be used for in vivo steatosis studies and drug screening.

Model Design for Screening Effective Antihyperlipidemic Drugs Using Zebrafish System.

Rapid analysis of hypolipidemic drugs in a live zebrafish assay

High Fat Plus High Cholesterol Diet Lead to Hepatic Steatosis in Zebrafish Larvae: a Novel Model for Screening Anti-Hepatic Steatosis Drugs

Optimizing Methods for the Study of Intravascular Lipid Metabolism in Zebrafish

Efficient and rapid liquid reduction animal model

A Comprehensive Study Of High Cholesterol Diet-Induced Larval Zebrafish Model: A Short-Time In Vivo Screening Method For Non-Alcoholic Fatty Liver Disease Drugs

Zebrafish Model for Screening Antiatherosclerosis Drugs.

A high-cholesterol zebrafish diet promotes hypercholesterolemia and fasting-associated liver steatosis

β-Sitosterol Reduces the Content of Triglyceride and Cholesterol in a High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Zebrafish (Danio rerio) Model

[Lipid-Lowering Effect of Seven Traditional Chinese Medicine Monomers in Zebrafish System].

Application of chrysophanol in zebrafish to reduce dietary introduced lipid and its possible mechanism.

A Zebrafish Heart Failure Model for Assessing Therapeutic Agents.

Effect of Emodin on Hyperlipidemia and Hepatic Lipid Metabolism in Zebrafish Larvae Fed a High-Cholesterol Diet

Establishment of a lipid metabolism disorder model in ApoEb mutant zebrafish

Hypolipidemic Effect of Rice Bran Oil Extract Tocotrienol in High-Fat Diet-Induced Hyperlipidemia Zebrafish (Danio Rerio) Induced by High-Fat Diet

Establishment of Danio rerio nutritional induced fatty liver model

Rutin ameliorates HCD-induced cholesterol metabolism disorder in zebrafish larvae revealed by transcriptome and metabolome analysis

Systemic Effect of Dietary Lipid Levels and Α-Lipoic Acid Supplementation on Nutritional Metabolism in Zebrafish ( Danio Rerio ): Focusing on the Transcriptional Level

A Novel 2-Hit Zebrafish Model to Study Early Pathogenesis of Non-Alcoholic Fatty Liver Disease

A Proof-of-Concept for a Hypolipidemic Brown Trout Model

Glycerol Monolaurate and Triglycerol Monolaurate Alleviated High-Fat Diet Induced Lipid Accumulation and Damage of Liver in Zebrafish (danio Rerio)